Strategic Partners A/S (OZYMF) Research

Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.

Market snapshot

Symbol
OZYMF
Price
$90.00
Day change
0.00%
Market cap
$23.6M
P/E ratio
-27.68x
52-week range
0.09-90
Sector
Healthcare
Industry
Biotechnology
Next earnings
in 3 months

Peer companies

  • Evelo Biosciences, Inc. (EVLO)
  • HEALTHeUNIVERSE, Inc. (HLUN)
  • NanoLogix, Inc. (NNLX)
  • PaxMedica, Inc. Common Stock (PXMD)
  • Q BioMed Inc. (QBIO)
  • SmileDirectClub, Inc. (SDCCQ)
  • Trevena, Inc. (TRVN)
  • North American Cannabis Holdings, Inc. (USMJ)

Open Strategic Partners A/S (OZYMF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.